Inhibikase Therapeutics Completes Amendment to Certificate of IncorporationAtlanta, Georgia – Inhibikase Therapeutics, Inc. (NYSE:IKT) recently announced the successful completion of a Special Meeting of Stockholders on January 3, 2025. During this m
This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Inhibikase Therapeutics’s 8K filing here. Inhibikase Therapeutics Company Profile (Get Free Report) Inhibikase Therapeutics, Inc, a clinical-stage pharmaceutical company, develops therapeutics for Parkinson’s disease and related disorders. Its lead product candidate is […]
More Stories
Cousins Properties (NYSE:CUZ) Stock Rating Lowered by StockNews.com
Cousins Properties (NYSE:CUZ – Get Free Report) was downgraded by investment analysts at StockNews.com from a “hold” rating to a...
Mohawk Industries (NYSE:MHK) Upgraded at StockNews.com
Mohawk Industries (NYSE:MHK – Get Free Report) was upgraded by investment analysts at StockNews.com from a “hold” rating to a...
StockNews.com Upgrades Viavi Solutions (NASDAQ:VIAV) to “Buy”
Viavi Solutions (NASDAQ:VIAV – Get Free Report) was upgraded by analysts at StockNews.com from a “hold” rating to a “buy”...
Wishbone Gold (LON:WSBN) Stock Price Down 4.2% – Should You Sell?
Shares of Wishbone Gold Plc (LON:WSBN – Get Free Report) dropped 4.2% during trading on Thursday . The company traded...
Aurinia Pharmaceuticals (NASDAQ:AUPH) Rating Increased to Strong-Buy at StockNews.com
Aurinia Pharmaceuticals (NASDAQ:AUPH – Get Free Report) (TSE:AUP) was upgraded by stock analysts at StockNews.com from a “buy” rating to...
Shoe Zone (LON:SHOE) Stock Passes Below 50-Day Moving Average – Here’s What Happened
Shares of Shoe Zone plc (LON:SHOE – Get Free Report) crossed below its fifty day moving average during trading on...